Stay updated with breaking news from Nasdaq Opnt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT – Get Rating) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $13.92 and traded as high as $20.26. Opiant Pharmaceuticals shares last traded at $20.26, with a volume of 2,200 shares. Analyst Upgrades and Downgrades OPNT has been the subject […]
Shares of Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT – Get Rating) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $12.49 and traded as high as $20.38. Opiant Pharmaceuticals shares last traded at $20.21, with a volume of 139,171 shares. Analyst Upgrades and Downgrades OPNT has been […]
Opiant Pharmaceuticals (NASDAQ:OPNT – Get Rating) and Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Volatility & Risk Opiant Pharmaceuticals has a beta of […]
SANTA MONICA, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), announced today that to protect the health...
Analysts expect Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT – Get Rating) to announce $7.13 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Opiant Pharmaceuticals’ earnings. The highest sales estimate is $10.00 million and the lowest is $5.70 million. Opiant Pharmaceuticals reported sales of $6.39 million during the same […]